{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T04:46:17Z","timestamp":1785905177691,"version":"3.56.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100022927","name":"State Board of Medical Research","doi-asserted-by":"publisher","award":["A2\/SBMR\/(2022-23)\/23210\/2022\/MCT"],"award-info":[{"award-number":["A2\/SBMR\/(2022-23)\/23210\/2022\/MCT"]}],"id":[{"id":"10.13039\/100022927","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Globally accelerated efforts are underway to eliminate dog-mediated rabies, underscoring the importance of effective anti-rabies prophylaxis. This study aims to assess the antibody response and its long-term persistence following rabies vaccination, their determinants, and suggest the optimal timing for a booster dose.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a retrospective cohort study among 150 participants, at the preventive clinic of Government Medical College, Thiruvananthapuram. Anti-rabies antibody titer in serum samples was estimated with the Rapid Fluorescent Foci Inhibition Test. To estimate the optimal timing for booster doses, the receiver operating characteristic (ROC) curve was plotted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Protective antibody titers (0.5 IU\/ml) were observed in 92.7% of participants, with a mean titer of 3.81 (3.31) IU\/ml. ROC analysis identified 5 years as a cut-off for booster dose. Regression analysis indicated a shorter time duration since last vaccination (P = .003) and intramuscular route (P = .005) as predictors of high antibody titers. However, the achievement of protective antibody titer was comparable for intramuscular and intradermal schedules.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Achievement of protective antibody titers is universal and long-lasting following anti-rabies vaccination, irrespective of the route of vaccination. Five years since the last dose could be used as an optimal cut-off for booster dose.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/trstmh\/trag055","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T11:46:30Z","timestamp":1776858390000},"page":"886-894","source":"Crossref","is-referenced-by-count":0,"title":["Antibody response following rabies vaccination: a retrospective cohort study from a tertiary centre in Kerala, India"],"prefix":"10.1093","volume":"120","author":[{"given":"Rahul","family":"Suresh","sequence":"first","affiliation":[{"name":"Government Medical College Department of Community Medicine, , Thiruvananthapuram 695011, Kerala ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6137-1492","authenticated-orcid":false,"given":"Chintha","family":"Sujatha","sequence":"additional","affiliation":[{"name":"Government Medical College Department of Community Medicine, , Thiruvananthapuram 695011, Kerala ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amala Panackal","family":"Saju","sequence":"additional","affiliation":[{"name":"Government Medical College Department of Community Medicine, , Thiruvananthapuram 695011, Kerala ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Sujatha","sequence":"additional","affiliation":[{"name":"State Institute for Animal Diseases , Palode, Thiruvananthapuram 695562, Kerala ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjana Nalinakumari Kesavan","family":"Nair","sequence":"additional","affiliation":[{"name":"Government Medical College Department of Community Medicine, , Thiruvananthapuram 695011, Kerala ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prathiush Prathapan","family":"Rema","sequence":"additional","affiliation":[{"name":"State Institute for Animal Diseases , Palode, Thiruvananthapuram 695562, Kerala ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Devarajan","sequence":"additional","affiliation":[{"name":"State Institute for Animal Diseases , Palode, Thiruvananthapuram 695562, Kerala ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuja","family":"Usha","sequence":"additional","affiliation":[{"name":"Government Medical College Department of Community Medicine, , Thiruvananthapuram 695011, Kerala ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreejith Lalitha","family":"Krishnankutty","sequence":"additional","affiliation":[{"name":"Health Services Department of , Thiruvananthapuram 695035, Kerala ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thekkumkara Surendran","family":"Anish","sequence":"additional","affiliation":[{"name":"Government Medical College Department of Community Medicine, , Thiruvananthapuram 695011, Kerala ,","place":["India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,9]]},"reference":[{"key":"2026080500013378200_bib1","doi-asserted-by":"crossref","first-page":"e0139171","DOI":"10.1371\/journal.pone.0139171","article-title":"Neutralizing antibody response after intramuscular purified vero cell rabies vaccination (PVRV) in Iranian patients with specific medical conditions","volume":"10","author":"Rahimi","year":"2015","journal-title":"PLoS One"},{"key":"2026080500013378200_bib2","author":"National Rabies Control Programme - National Centre for Disease Control (NCDC)"},{"key":"2026080500013378200_bib3"},{"key":"2026080500013378200_bib4","doi-asserted-by":"crossref","first-page":"A99","DOI":"10.1016\/j.vaccine.2018.11.072","article-title":"An overview of the immunogenicity and effectiveness of current human rabies vaccines administered by intradermal route","volume":"37","author":"Denis","year":"2019","journal-title":"Vaccine"},{"key":"2026080500013378200_bib5","volume-title":"WHO Expert Committee on Biological Standardization: Fifty-Sixth Report","author":"WHO","year":"2007"},{"key":"2026080500013378200_bib6","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.vaccine.2021.01.023","article-title":"Immunogenicity after pre- and post-exposure rabies vaccination: a systematic review and dose-response meta-analysis","volume":"39","author":"Xu","year":"2021","journal-title":"Vaccine"},{"key":"2026080500013378200_bib7","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1089\/vbz.2019.2526","article-title":"Antibody response following pre-exposure immunization against rabies in high-risk professionals","volume":"20","author":"Dougas","year":"2020","journal-title":"Vector-Borne Zoonotic Dis"},{"key":"2026080500013378200_bib8","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1080\/21645515.2021.1880200","article-title":"Safety, immunogenicity of lyophilized purified vero cell cultured rabies vaccine administered in Zagreb and Essen regimen in post-exposure subjects: a post-marketing, parallel control clinical trial","volume":"17","author":"Zhang","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"2026080500013378200_bib9","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1016\/j.vaccine.2020.03.043","article-title":"Single-visit, 4-site intradermal (ID) rabies vaccination induces robust immune responses 5 years after 1-week, 4-site ID primary post-exposure prophylaxis in the Philippines","volume":"38","author":"Quiambao","year":"2020","journal-title":"Vaccine"},{"key":"2026080500013378200_bib10","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.vaccine.2006.12.012","article-title":"Multicenter comparative study of a new ELISA, PLATELIA RABIES II, for the detection and titration of anti-rabies glycoprotein antibodies and comparison with the rapid fluorescent focus inhibition test (RFFIT) on human samples from vaccinated and non-vaccinated people","volume":"25","author":"Feyssaguet","year":"2007","journal-title":"Vaccine"},{"key":"2026080500013378200_bib11","volume-title":"WOAH\u2014World Organisation for Animal Health","author":"Terrestrial Manual Online Access"},{"key":"2026080500013378200_bib12"},{"key":"2026080500013378200_bib13","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.4103\/jfmpc.jfmpc_890_20","article-title":"Factors influencing delay in initiating post-exposure prophylaxis for rabies prevention among animal bite victims: a cross sectional study","volume":"9","author":"Wani","year":"2020","journal-title":"J Family Med Primary Care"},{"key":"2026080500013378200_bib14","doi-asserted-by":"crossref","first-page":"taab188","DOI":"10.1093\/jtm\/taab188","article-title":"Long-term persistence of antibodies and boostability after rabies intradermal pre-exposure prophylaxis","volume":"29","author":"Mills","year":"2022","journal-title":"J Travel Med"},{"key":"2026080500013378200_bib15","doi-asserted-by":"crossref","first-page":"e0004920","DOI":"10.1371\/journal.pntd.0004920","article-title":"Persistence of rabies virus-neutralizing antibodies after vaccination of rural population following vampire bat rabies outbreak in Brazil","volume":"10","author":"Medeiros","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"2026080500013378200_bib16","first-page":"40","article-title":"Purified Vero cell rabies vaccine (PVRV, Verorab\u00ae): a systematic review of intradermal use between 1985 and 2019","volume":"5","author":"Moulenat","year":"2020","journal-title":"Trop Med"},{"key":"2026080500013378200_bib17","first-page":"268","article-title":"Post-exposure prophylaxis against rabies at two newly designated intradermal rabies vaccination clinics in Kerala, India","volume":"25","author":"Teena","year":"2012","journal-title":"Natl Med J India"},{"key":"2026080500013378200_bib18","doi-asserted-by":"crossref","first-page":"taaa006","DOI":"10.1093\/jtm\/taaa006","article-title":"Intradermal rabies pre-exposure vaccination schedules in older travellers: comparison of immunogenicity post-primary course and post-booster","volume":"27","author":"Furuya-Kanamori","year":"2020","journal-title":"J Travel Med"},{"key":"2026080500013378200_bib19","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/cid\/ciad304","article-title":"Side-by-side comparative study of the immunogenicity of the intramuscular and intradermal rabies post-exposure prophylaxis regimens in a cohort of suspected rabies virus exposed individuals","volume":"77","author":"Auerswald","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2026080500013378200_bib20","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.4161\/hv.20471","article-title":"Evaluation of a one week intradermal regimen for rabies post-exposure prophylaxis: results of a randomized, open label, active-controlled trial in healthy adult volunteers in India","volume":"8","author":"Sudarshan","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"2026080500013378200_bib21","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1016\/j.vaccine.2016.09.058","article-title":"Rabies pre-exposure prophylaxis elicits long-lasting immunity in humans","volume":"34","author":"Mansfield","year":"2016","journal-title":"Vaccine"},{"key":"2026080500013378200_bib22","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1399-3062.2011.00665.x","article-title":"Immune response after rabies vaccine in a kidney transplant recipient","volume":"13","author":"Rodr\u00edguez-Romo","year":"2011","journal-title":"Transplant Infect Dis"},{"key":"2026080500013378200_bib23","doi-asserted-by":"crossref","first-page":"E122","DOI":"10.1086\/324087","article-title":"Failure of multiple-site intradermal postexposure rabies vaccination in patients with human immunodeficiency virus with low CD4+ T lymphocyte counts","volume":"33","author":"Tantawichien","year":"2001","journal-title":"Clin Infect Dis"},{"key":"2026080500013378200_bib24","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.3201\/eid1809.111833","article-title":"Inadequate antibody response to rabies vaccine in immunocompromised patient","volume":"18","author":"Kopel","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"2026080500013378200_bib25","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1080\/21645515.2015.1048938","article-title":"Comparison of safety and immunogenicity of 2 WHO prequalified rabies vaccines administered by one week, 4 site intra dermal regimen (4-4-4-0-0) in animal bite cases","volume":"11","author":"Narayana","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"2026080500013378200_bib26","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3390\/vaccines12111209","article-title":"Immunogenicity persistence of different immunization regimens of rabies vaccine in the 10\u201360 years age group: a follow-up report based on phase III clinical trial","volume":"12","author":"Wang","year":"2024","journal-title":"Vaccines"},{"key":"2026080500013378200_bib27","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1016\/j.vaccine.2006.02.027","article-title":"Survival of neutralizing antibody in previously rabies vaccinated subjects: a prospective study showing long lasting immunity","volume":"24","author":"Suwansrinon","year":"2006","journal-title":"Vaccine"},{"key":"2026080500013378200_bib28","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2471\/BLT.16.173039","article-title":"Pre-exposure rabies prophylaxis: a systematic review","volume":"95","author":"Kessels","year":"2017","journal-title":"Bull World Health Organisation"},{"key":"2026080500013378200_bib29","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1016\/j.vaccine.2010.03.039","article-title":"The immune response to rabies virus infection and vaccination","volume":"28","author":"Johnson","year":"2010","journal-title":"Vaccine"}],"container-title":["Transactions of The Royal Society of Tropical Medicine and Hygiene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/trstmh\/article-pdf\/120\/8\/886\/68258546\/trag055.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/trstmh\/article-pdf\/120\/8\/886\/68258546\/trag055.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T04:01:47Z","timestamp":1785902507000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/trstmh\/article\/120\/8\/886\/8674881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,9]]},"references-count":29,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,5,9]]},"published-print":{"date-parts":[[2026,8,5]]}},"URL":"https:\/\/doi.org\/10.1093\/trstmh\/trag055","relation":{},"ISSN":["0035-9203","1878-3503"],"issn-type":[{"value":"0035-9203","type":"print"},{"value":"1878-3503","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,5,9]]}}}